Very Thinly traded share , significant Director buying recently , heavily manipulated , was in , now out , too ride a wild for me. Nice divvies if that’s your thing. GLA.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
